Hemodynamic changes and cytokine trends during abdominal stop-flow
نویسندگان
چکیده
منابع مشابه
Comparison of hemodynamic changes of Propofol and Thiopental during
Introduction: General anesthesia is the most common technique for performance of various surgical procedures. Thiopental is the most common anesthetic agent for intravenous induction. Since the introduction of propofol as an anesthetic agent, its use has increased progressively and has become the drug of choice for induction of anesthesia in several conditions. The aims of this study were com...
متن کاملStop Flow in abdominal and pelvic cancer relapses.
To determinate MTD, DLT and safe doses for phase II study, a dose finding study with Mitomycin and Adriamycin Stop-Flow administration was carried out. A phase II study focused on resectability of pelvic colorectal relapses is in progress. From November 1995, 84 pts, 52 male and 32 female (94 treatments), with advanced not resectable abdominal (14 pts) or pelvic (70 pts) relapses, and resistant...
متن کاملHemodynamic Changes during Thiopental Anesthesia
Thiopental, monosodium 5-ethyl-5(1-methylbutyl) -thiobarbiturate, is extensively used in clinical anesthesia either as a primary anesthetic agent for short surgical procedures or as a supplementary drug in conjunction with other anesthetics. Fatalities have been attributed to its use (1, 2) and cardiac arrest has occurred following its administration to patients under spinal anesthesia (3). Mos...
متن کاملHemodynamic changes during sleep in hypertensive patients.
Hemodynamic studies were carried out during nonsedated all-night sleep on 14 patients with established hypertension. The significant changes from awake control values were as follows: mean arterial pressure fell 7.3% in stages I and II sleep and 8.8% in deep (stages III and IV) sleep; cardiac output decreased 10.3, 9.8, and 8.8% in stages I, II, and III and IV sleep, respectively; heart rate fe...
متن کاملMeasuring hemodynamic changes during mammalian development.
The pathogenesis of many congenital cardiovascular diseases involves abnormal flow within the embryonic vasculature that results either from malformations of the heart or defects in the vasculature itself. Extensive genetic and genomic analysis in mice has led to the identification of an array of mutations that result in cardiovascular defects during embryogenesis. Many of these mutations cause...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Critical Care
سال: 1999
ISSN: 1364-8535
DOI: 10.1186/cc550